PAG
RNAM

Private Advisor Group’s Avidity Biosciences RNAM Stock Holding History

Private Advisor Group’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,000
Closed -$216K – 2825
2025
Q4 		$216K Sell
3,000
-1,713
-36% -$111K ﹤0.01% 2358
2025
Q3 		$205K Buy
+4,713
New +$191K ﹤0.01% 2316

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Private Advisor Group's RNAM Position: Q1 2026 in Review

Private Advisor Group sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 3,000 shares — an estimated $216K sold.

Private Advisor Group first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $216K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Private Advisor Group reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Private Advisor Group sold 3,000 Avidity Biosciences shares in Q1 2026, an estimated $216K.
  • Private Advisor Group first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
  • Private Advisor Group's Avidity Biosciences position peaked at $216K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.